Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.335
-0.395 (-14.47%)
At close: Nov 2, 2026, 4:00 PM EST
2.370
+0.035 (1.50%)
Pre-market: Nov 3, 2026, 8:51 AM EST
Nautilus Biotechnology Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Nautilus Biotechnology stock have an average target of $4.00, which predicts a 71.31% increase from the current stock price of 2.34.
Price Target: $4.00 (+71.31%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nautilus Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | Jul '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Maintains $3.5 → $4 | Buy | Maintains | $3.5 → $4 | +71.31% | Oct 28, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $4 | Buy | Reiterates | $4 | +71.31% | Oct 28, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Initiates $4 | Buy | Initiates | $4 | +71.31% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
691.33K
Revenue Next Year
5.59M
from 691.33K
Increased by 708.84%
EPS This Year
-0.61
EPS Next Year
-0.60
from -0.61
EPS and Forward PE are based on non-GAAP adjusted numbers.